209 related articles for article (PubMed ID: 26207141)
1. Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas.
Sha C; Barrans S; Care MA; Cunningham D; Tooze RM; Jack A; Westhead DR
Genome Med; 2015; 7(1):64. PubMed ID: 26207141
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of gene expression platforms for cell-of-origin classification of diffuse large B-cell lymphoma shows high concordance.
Ahmed S; Glover P; Taylor J; Sha C; Care MA; Tooze R; Davies A; Westhead DR; Johnson PWM; Burton C; Barrans SL
Br J Haematol; 2021 Feb; 192(3):599-604. PubMed ID: 33249557
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue.
Masqué-Soler N; Szczepanowski M; Kohler CW; Aukema SM; Nagel I; Richter J; Siebert R; Spang R; Burkhardt B; Klapper W
Br J Haematol; 2015 Nov; 171(4):501-8. PubMed ID: 26218299
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridisation analysis of formalin-fixed paraffin-embedded tissue sections in the diagnostic work-up of non-Burkitt high grade B-cell non-Hodgkin's lymphoma: a single centre's experience.
Foot NJ; Dunn RG; Geoghegan H; Wilkins BS; Neat MJ
J Clin Pathol; 2011 Sep; 64(9):802-8. PubMed ID: 21593346
[TBL] [Abstract][Full Text] [Related]
5. Molecular signatures that can be transferred across different omics platforms.
Altenbuchinger M; Schwarzfischer P; Rehberg T; Reinders J; Kohler CW; Gronwald W; Richter J; Szczepanowski M; Masqué-Soler N; Klapper W; Oefner PJ; Spang R
Bioinformatics; 2017 Jul; 33(14):i333-i340. PubMed ID: 28881975
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data Sets.
Faruki H; Mayhew GM; Fan C; Wilkerson MD; Parker S; Kam-Morgan L; Eisenberg M; Horten B; Hayes DN; Perou CM; Lai-Goldman M
Arch Pathol Lab Med; 2016 Jun; 140(6):536-42. PubMed ID: 26430809
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma: sub-classification by massive parallel quantitative RT-PCR.
Xue X; Zeng N; Gao Z; Du MQ
Lab Invest; 2015 Jan; 95(1):113-20. PubMed ID: 25418578
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
[TBL] [Abstract][Full Text] [Related]
9. Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas.
Seegmiller AC; Garcia R; Huang R; Maleki A; Karandikar NJ; Chen W
Mod Pathol; 2010 Jul; 23(7):909-20. PubMed ID: 20348878
[TBL] [Abstract][Full Text] [Related]
10. Microarray gene expression analysis of fixed archival tissue permits molecular classification and identification of potential therapeutic targets in diffuse large B-cell lymphoma.
Linton K; Howarth C; Wappett M; Newton G; Lachel C; Iqbal J; Pepper S; Byers R; Chan WJ; Radford J
J Mol Diagn; 2012; 14(3):223-32. PubMed ID: 22446084
[TBL] [Abstract][Full Text] [Related]
11. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
12. Scoring of MYC protein expression in diffuse large B-cell lymphomas: concordance rate among hematopathologists.
Mahmoud AZ; George TI; Czuchlewski DR; Zhang QY; Wilson CS; Sever CE; Bakhirev AG; Zhang D; Steidler NL; Reichard KK; Kang H; Foucar K; Vasef MA
Mod Pathol; 2015 Apr; 28(4):545-51. PubMed ID: 25431238
[TBL] [Abstract][Full Text] [Related]
13. Molecular Subtyping of Diffuse Large B-Cell Lymphoma Using a Novel Quantitative RT-PCR Assay.
Ta R; Santini C; Gou P; Lee G; Tai YC; O'Brien C; Fontecha M; Grant C; Bacon L; Finn S; Vandenberghe E; Quinn F; Dua R; Flavin R
J Mol Diagn; 2021 Mar; 23(3):323-340. PubMed ID: 33385586
[TBL] [Abstract][Full Text] [Related]
14. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
[TBL] [Abstract][Full Text] [Related]
15. Accurate Classification of Germinal Center B-Cell-Like/Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase-Multiplex Ligation-Dependent Probe Amplification Assay: A CALYM Study.
Mareschal S; Ruminy P; Bagacean C; Marchand V; Cornic M; Jais JP; Figeac M; Picquenot JM; Molina TJ; Fest T; Salles G; Haioun C; Leroy K; Tilly H; Jardin F
J Mol Diagn; 2015 Apr; ():. PubMed ID: 25891505
[TBL] [Abstract][Full Text] [Related]
16. A microarray platform-independent classification tool for cell of origin class allows comparative analysis of gene expression in diffuse large B-cell lymphoma.
Care MA; Barrans S; Worrillow L; Jack A; Westhead DR; Tooze RM
PLoS One; 2013; 8(2):e55895. PubMed ID: 23424639
[TBL] [Abstract][Full Text] [Related]
17. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
18. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
[TBL] [Abstract][Full Text] [Related]
20. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]